In Vitro Toxicology Testing Market Size Forecast To 2027 | Key Company Profile – GE Healthcare, Covance, Thermo Fisher Scientific, Eurofins Scientific SE, Promega Corporation

Precision Business Insights published a research report on “In Vitro Toxicology Testing Market By Product (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Tissue Culture Assays, Western Blots, Cell Based ELISA, Receptor Binding Assays), By Technology (Cellular Imaging Technology, High Throughput Technology, Toxic Genomics, Cell Culture Technology), By Endpoint (Skin Sensitization and Irritation, Cytotoxicity, Neurotoxicity, Geno Toxicity, Ocular Toxicity, Photo Toxicity, Carcinogenicity, Organ Toxicity, Dermal Toxicity), By Method (Ex Vivo Models, Cellular Assays, Biochemical Assays), By End User (Pharmaceutical Industry, Biopharmaceutical Industry, Cosmetics Industry, Household Products Industry, Chemicals Industry, Food Industry), and By Geography - Global/Region/Country Forecast to 2027” The Global In Vitro Toxicology Testing Market USD 8.7 Billion in 2020 and is anticipated to grow at USD 17.5 Billion till 2027 recording a CAGR of 10.5% during the forecast period 2021-2027”

Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on "Global In Vitro Toxicology Testing Market By Product (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Tissue Culture Assays, Western Blots, Cell Based ELISA, Receptor Binding Assays), By Technology (Cellular Imaging Technology, High Throughput Technology, Toxic Genomics, Cell Culture Technology), By Endpoint (Skin Sensitization and Irritation, Cytotoxicity, Neurotoxicity, Geno Toxicity, Ocular Toxicity, Photo Toxicity, Carcinogenicity, Organ Toxicity, Dermal Toxicity), By Method (Ex Vivo Models, Cellular Assays, Biochemical Assays), By End User (Pharmaceutical Industry, Biopharmaceutical Industry, Cosmetics Industry, Household Products Industry, Chemicals Industry, Food Industry), and By Geography - Global/Region/Country Forecast to 2027"

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/in-vitro-toxicology-testing-market/

Increase in Healthcare Problems will accelerate the Global in Vitro Toxicology Testing Market
In vitro toxicology testing refers to the effects of the toxic substances on bacteria or cultured mammalian cells. It is mainly used to identify possible dangerous chemicals for confirming the definite toxic properties at early growth stages of therapeutic drugs. Growing demand for in vitro toxicology tests, growing advanced technologies and increase in research development activities in cell cultures are anticipated to impel the revenue growth of the market. In addition, increase in economic condition of developing regions, increasing awareness among people about in vitro toxicology tests and growing healthcare related problems amid individuals are projected to create several growth opportunities for global in vitro toxicology testing market. However, technological disadvantages, strict regulatory framework and dearth of in vitro models for the detection of auto immunity and immune stimulation can restrain the market.

In vitro toxicology testing market is hugely segmented because of the presence of several key players anticipated to provide profitable growth during the forecast time span 2021-2027. These key players concentrate more on introducing pioneering technologies, developing new software solutions and augmenting in silico simulation techniques in toxicology profiling. Industries in the market aim at implementing different growth strategies including acquisitions, collaborations mergers, and launches for retaining their position and expanding their product collection in the market. For example, Aspect Biosystes made collaboration with Fraunhhofer ITEM and InSCREENex GmbH for the application of Lab on a Printer Bio Printing technology for creating new tissues, which may be utilized for improving the reliability of pre-clinical toxicity test.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=19052

Europe is projected to dominate the Global in Vitro Toxicology Testing Market
On the basis of regional analysis, global in vitro toxicology testing market is classified into major regions such as Europe, North America, Latin America, Africa and The Middle East. Europe is anticipated to dominate the market followed by North America owing to favorable government support and rising cosmetic product testing. Asia Pacific is projected to experience robust growth due to the growing population, growing medical tourism in rising countries of this region, low price of developments and growing disposable income.

Competitive Analysis
A few major key players of the global in vitro toxicology testing market are Cyprotex (Germany), GE Healthcare (U.S.), Covance (U.S.), Thermo Fisher Scientific (U.S.), Eurofins Scientific SE (Luxembourg), Promega Corporation (U.S.), SGS SA (Switzerland), Merck KGaA (Germany), Lonza Group Ltd. (Switzerland) and Charles River Laboratories, Inc. (U.S.).

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.